Drugs / Intramyocardial mesenchymal stem cell transplantation
Intramyocardial mesenchymal stem cell transplantation
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00418418 Comparator | Oct 2006 → Dec 2009 | coronary artery disorder, myocardial infarction, systolic heart failure | University of Helsinki | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intramyocardial mesenchymal stem cell transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00418418 ↗ |
| Modality | Cell therapy | “mesenchymal stem cell transplantation” NCT00418418 ↗ |
| Route | Other | “stem cells are directly injected to myocardium” NCT00418418 ↗ |